HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 41, 38345-38349, October 11, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/41/38345    most recent M206959200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doering, C. B. Articles by Lollar, P. Search for Related Content PubMed PubMed Citation Articles by Doering, C. B. Articles by Lollar, P. Social Bookmarking                      What's this?

High Level Expression of Recombinant Porcine Coagulation Factor VIII^*

Christopher B. Doering, John F. Healey, Ernest T. Parker, Rachel T. Barrow, and Pete Lollar

From the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322

Recombinant human factor VIII expression levels, in vitro and in vivo, are significantly lower than levels obtained for other recombinant coagulation proteins. Here we describe the generation, high level expression and characterization of a recombinant B-domain-deleted porcine factor VIII molecule. Recombinant B-domain-deleted porcine factor VIII expression levels are 10- to 14-fold greater than recombinant B-domain-deleted human factor VIII levels by transient and stable expression in multiple cell lines. Peak expression of 140 units·10⁶ cells¹·24 h¹ was observed from a baby hamster kidney-derived cell line stably expressing recombinant porcine factor VIII. Factor VIII expression was performed in serum-free culture medium and in the absence of exogenous von Willebrand factor, thus greatly simplifying protein purification. Real time reverse transcription-PCR analysis demonstrated that the differences in protein production were not caused by differences in steady-state factor VIII mRNA levels. The identification of sequence(s) in porcine factor VIII responsible for high level expression may lead to a better understanding of the mechanisms that limit factor VIII expression.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. T. Parker, C. B. Doering, and P. Lollar A1 Subunit-mediated Regulation of Thrombin-activated Factor VIII A2 Subunit Dissociation J. Biol. Chem., May 19, 2006; 281(20): 13922 - 13930. [Abstract] [Full Text] [PDF]

				B. Gangadharan, E. T. Parker, L. M. Ide, H. T. Spencer, and C. B. Doering High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells Blood, May 15, 2006; 107(10): 3859 - 3864. [Abstract] [Full Text] [PDF]

				E. T. Parker, J. F. Healey, R. T. Barrow, H. N. Craddock, and P. Lollar Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope Blood, August 1, 2004; 104(3): 704 - 710. [Abstract] [Full Text] [PDF]

				C. B. Doering, J. F. Healey, E. T. Parker, R. T. Barrow, and P. Lollar Identification of Porcine Coagulation Factor VIII Domains Responsible for High Level Expression via Enhanced Secretion J. Biol. Chem., February 20, 2004; 279(8): 6546 - 6552. [Abstract] [Full Text] [PDF]